Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Injecto Group A/S - Group Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmarkIFRS Analyst: XBRLDenmarkIFRS

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2018 2018/8 2019 2019/8 2020 2020/8 2021 2021/8 2022 2022/8 2023 2023/8 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 2.2% 2.2%   Bankruptcy risk   13.1% 17.5% 9.5% 4.9% 6.6% 3.7% 14.0% 14.0%   Credit score (0-100)   19 10 26 43 35 51 16 16   Credit rating   BB B BB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/8 2019 2019/8 2020 2020/8 2021 2021/8 2022 2022/8 2023 2023/8 2024e N/A 2025e N/A Net sales   100 100 100 707 718 1,813 1,813 1,813   Gross profit   -1,935 -2,403 -3,687 -3,463 -4,293 -3,128 0.0 0.0   EBITDA   -4,801 -4,137 -5,299 -5,026 -8,019 -5,994 0.0 0.0   EBIT   -5,206 -4,434 -7,740 -8,024 -11,639 -9,351 0.0 0.0   Pre-tax profit (PTP)   -5,234.4 -4,429.9 -8,836.2 -9,457.4 -11,825.3 -9,329.8 0.0 0.0   Net earnings   -5,234.4 -4,429.9 -9,531.5 -9,457.4 -13,116.1 -9,329.8 0.0 0.0   Pre-tax profit without non-rec. items   -5,234 -4,430 -8,836 -9,457 -11,825 -9,330 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/8 2019 2019/8 2020 2020/8 2021 2021/8 2022 2022/8 2023 2023/8 2024e N/A 2025e N/A Tangible assets total   942 1,209 1,195 2,204 1,890 2,490 0.0 0.0   Shareholders equity total   7,604 3,326 28,404 25,403 40,665 55,064 -58,748 -58,748   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 0.0 58,748 58,748   Balance sheet total (assets)   9,067 9,633 45,070 46,088 42,196 56,810 0.0 0.0   Net Debt   -1,901 -824 -1,270 -2,162 -906 -4,858 58,748 58,748     See the entire balance sheet 1000.0 Volume  2018 2018/8 2019 2019/8 2020 2020/8 2021 2021/8 2022 2022/8 2023 2023/8 2024e N/A 2025e N/A Net sales   100 100 100 707 718 1,813 1,813 1,813   Net sales growth   0.0% 0.0% 0.0% 606.7% 1.7% 152.3% 0.0% 0.0%   Gross profit   -1,935 -2,403 -3,687 -3,463 -4,293 -3,128 0.0 0.0   Gross profit growth   -48.9% -24.2% -53.4% 6.1% -24.0% 27.1% 0.0% 0.0%   Employees   0 0 0 0 0 2 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   9,067 9,633 45,070 46,088 42,196 56,810 0 0   Balance sheet change%   73.0% 6.2% 367.9% 2.3% -8.4% 34.6% -100.0% 0.0%   Added value   -5,205.5 -4,434.5 -7,740.0 -8,024.1 -11,638.8 -9,351.0 0.0 0.0   Added value %   -5,205.5% -4,434.5% -7,740.0% -1,135.4% -1,619.9% -515.8% 0.0% 0.0%   Investments   417 4,965 33,159 -3,089 -43,443 -2,757 -2,490 0   Net sales trend   0.0 0.0 0.0 1.0 2.0 3.0 0.0 0.0   EBIT trend   -3.0 -4.0 -5.0 -5.0 -5.0 -5.0 0.0 0.0   1000.0 Profitability  2018 2018/8 2019 2019/8 2020 2020/8 2021 2021/8 2022 2022/8 2023 2023/8 2024e N/A 2025e N/A EBITDA %   -4,801.4% -4,136.8% -5,298.8% -711.2% -1,116.2% -330.6% 0.0% 0.0%   EBIT %   -5,205.5% -4,434.5% -7,740.0% -1,135.4% -1,619.9% -515.8% 0.0% 0.0%   EBIT to gross profit (%)   269.0% 184.5% 209.9% 231.7% 271.1% 298.9% 0.0% 0.0%   Net Earnings %   -5,234.4% -4,429.9% -9,531.5% -1,338.3% -1,825.6% -514.6% 0.0% 0.0%   Profit before depreciation and extraordinary items %   -4,830.4% -4,132.2% -7,090.3% -914.0% -1,321.8% -329.4% 0.0% 0.0%   Pre tax profit less extraordinaries %   -5,234.4% -4,429.9% -8,836.2% -1,338.3% -1,645.9% -514.6% 0.0% 0.0%   ROA %   -72.7% -45.2% -28.2% -17.5% -26.3% -18.8% 0.0% 0.0%   ROI %   -80.9% -71.1% -40.5% -20.2% -27.1% -19.4% 0.0% 0.0%   ROE %   -84.7% -81.0% -60.1% -35.1% -39.7% -19.5% 0.0% 0.0%   1000.0 Solidity  2018 2018/8 2019 2019/8 2020 2020/8 2021 2021/8 2022 2022/8 2023 2023/8 2024e N/A 2025e N/A Equity ratio %   83.9% 34.5% 63.0% 55.1% 96.4% 96.9% -100.0% -100.0%   Relative indebtedness %   1,463.0% 6,306.4% 16,665.5% 2,927.0% 213.0% 96.3% 3,240.4% 3,240.4%   Relative net indebtedness %   -437.8% 5,482.3% 15,395.8% 2,621.1% 86.9% -171.7% 3,240.4% 3,240.4%   Net int. bear. debt to EBITDA, %   39.6% 19.9% 24.0% 43.0% 11.3% 81.1% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/8 2019 2019/8 2020 2020/8 2021 2021/8 2022 2022/8 2023 2023/8 2024e N/A 2025e N/A Quick Ratio   2.4 0.2 0.2 2.4 1.5 3.9 0.0 0.0   Current Ratio   2.4 0.2 0.2 2.4 1.5 3.9 0.0 0.0   Cash and cash equivalent   1,900.8 824.1 1,269.7 2,161.6 906.0 4,858.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/8 2019 2019/8 2020 2020/8 2021 2021/8 2022 2022/8 2023 2023/8 2024e N/A 2025e N/A Trade debtors turnover (days)   1,159.5 1,642.5 2,080.5 366.7 480.2 77.5 0.0 0.0   Trade creditors turnover (days)   134.8 85.9 61.5 58.7 71.5 70.4 0.0 0.0   Current assets / Net sales %   2,311.0% 1,420.2% 1,952.0% 433.2% 280.1% 348.6% 0.0% 0.0%   Net working capital   1,348.0 -4,436.3 -8,761.2 1,780.4 631.7 4,705.1 -29,373.8 -29,373.8   Net working capital %   1,348.0% -4,436.3% -8,761.2% 251.9% 87.9% 259.5% -1,620.2% -1,620.2%   1000.0 Employee efficiency  2018 2018/8 2019 2019/8 2020 2020/8 2021 2021/8 2022 2022/8 2023 2023/8 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 906 0 0   Added value / employee   0 0 0 0 0 -4,676 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 -2,997 0 0   EBIT / employee   0 0 0 0 0 -4,676 0 0   Net earnings / employee   0 0 0 0 0 -4,665 0 0